Indivior (INDV) Health Care Sector

  • Latest quote

    44.76p (mid)

  • Current Change (%)

    -0.53%

  • Price

    Bid: 44.71p

    Offer: 44.85p

  • Today

    High: 45.65p

    Low: 43.69p

  • This year

    High: 385.10p

    Low: 30.05p

  • Information

    Volume: 1,670,676

    Market Cap: £327.41M



Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Indivior RNS Feed

Title Release date
Indivior Presents RECOVER Study Data at CPDD 2019 12:31 - June 18, 2019
Holding(s) in Company 08:47 - June 14, 2019
Holding(s) in Company 07:00 - May 29, 2019
Holding(s) in Company 09:04 - May 24, 2019
Holding(s) in Company 09:55 - May 17, 2019
Indivior to Participate in Conference 07:00 - May 16, 2019
Director/PDMR Shareholding 07:00 - May 15, 2019
Director/PDMR Shareholding 15:43 - May 13, 2019
Holding(s) in Company 07:00 - May 13, 2019
Holding(s) in Company 07:00 - May 13, 2019
Licensing of PERSERIS in Canada 11:30 - May 9, 2019
Block listing Interim Review 10:29 - May 9, 2019
Result of AGM 13:54 - May 8, 2019
Holding(s) in Company 07:00 - May 3, 2019
1st Quarter Results 12:00 - May 2, 2019

NOTE: This is based on 36 open tips for this company


Total Number of Share tips :

55

View all Indivior Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today